Rotem Industries - Medical Imaging
Alon Sabaton is a skilled engineer with expertise in research and development, particularly in mechanical engineering. Currently serving as an R&D Mechanical Engineer at Rotem Industries since March 2023, Alon conducts multidisciplinary research and develops comprehensive engineering reports. Prior experience includes a role as an R&D and Maintenance Engineer at the Israel Ministry of Defence from October 2018 to March 2023, where Alon focused on mechanical R&D, strength simulations, and project management. Additionally, Alon worked as a Mechanical Maintenance Engineer at Osem - Nestle between September 2017 and October 2018, leading maintenance efforts and utilizing innovative methods for project management. Alon holds a Bachelor's degree in Mechanical Engineering from Ben-Gurion University of the Negev, earned in September 2017.
This person is not in any teams
Rotem Industries - Medical Imaging
Hi-tech company specializing in the development and commercialization of technologies from research centers and start-ups. Rotem markets its products worldwide and has subsidiaries in the USA and Germany. Main business areas are medical imaging, crystal manufacturing, radiation detection and renewable energy. Rotem Industries' Medical Imaging business is a world leader in consumables for PET imaging. Rotem develops, manufactures and supplies complete packages for the production of radiotracers: oxygen-18 enriched water, plastic cassettes, precursors and complete reagent kits for a range of synthesis modules. Rotem serves its customers through a global distribution network, and Rotem excels in uncompromising product quality coupled with a deep understanding of customer needs to ensure uniformly high production yields and unsurpassed quality. The passion for quality is driven by a team of highly skilled and dedicated professionals who recognize the critical role their products play in the PET radiotracer production chain. Rotem is very active in the development and production of consumables for new radiotracers under development. These projects benefit from our interdisciplinary expertise and direct market access, which is the result of years of direct, day-to-day, close collaboration with radiopharmaceutical companies worldwide.